Skopos Labs, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Skopos Labs, Inc.
- $330 Million
- Q4 2024
A detailed history of Skopos Labs, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 94 shares of HRMY stock, worth $3,716. This represents 0.0% of its overall portfolio holdings.
Number of Shares
94Holding current value
$3,716% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
247Shares Held
45.5MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$444 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$231 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$137 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$103 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$90.1 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.34B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...